Optimum chemotherapy in the management of metastatic pancreatic cancer

doi:10.3748/wjg.v20.i9.2352

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 20, Issue 9

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6881)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-4) series.

Item

Count

PDF

429

WORD

243

HTML

3719

Figures (1-1)

239

Tables (1-4)

208

Sum=4838

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1004

Download

1039

Sum=2043

Mar 7, 2014 (publication date) through Nov 30, 2024

Times Cited of This Article

Times Cited (15)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Topic Highlight

World J Gastroenterol. Mar 7, 2014; 20(9): 2352-2357
Published online Mar 7, 2014. doi: 10.3748/wjg.v20.i9.2352

Table 1 Summary of the results of four trials associating Gemcitabine and targeted therapies

Ref.	Regimen	ORR	Median PFS (mo)	Median OS (mo)
Philip et al[10]	Gem/cetuximab	12.5%	3.4	6.3
Philip et al[10]	Gem	14.0%	3	5.9
Kindler et al[11]	Gem/bevacizumab	13.0%	3.8	5.8
Kindler et al[11]	Gem	10.0%	2.9	5.9
Moore et al[12]	Gem/erlotinib	8.6%	3.75	6.24
Moore et al[12]	Gem	8.0%	3.55	5.91
Rougier et al[13]	Gem/aflibercept	ND	3.7	6.5
Rougier et al[13]	Gem	ND	3.7	7.8

ORR: Objective response rate; PFS: Progression free survival; OS: Overall survival; ND: Not determined.

Citation: Ghosn M, Kourie HR, Karak FE, Hanna C, Antoun J, Nasr D. Optimum chemotherapy in the management of metastatic pancreatic cancer. World J Gastroenterol 2014; 20(9): 2352-2357
URL: https://www.wjgnet.com/1007-9327/full/v20/i9/2352.htm
DOI: https://dx.doi.org/10.3748/wjg.v20.i9.2352